What predetermines the therapeutic tactics of a physician in the treatment of dementia? Results of a survey of Russian physicians
Open Access
- 31 July 2022
- journal article
- Published by V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology in V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY
- Vol. 56 (2), 78-89
- https://doi.org/10.31363/2313-7053-2022-56-2-78-89
Abstract
In order to study the point of view of doctors supervising patients with dementia regarding the methods and tactics of treating diseases that occur with severe cognitive impairment, their experience in the use of drugs and criteria for choosing a drug for long-term treatment of dementia, an online survey of 197 specialists was conducted.The majority of Russian physicians surveyed prefer basic therapy for dementia, while the main criteria for choosing a drug for long-term therapy are effectiveness and safety of the drug. Despite the absence of drugs capable of complete curing of dementia, Russian doctors have certain expectations and goals when prescribing therapy, in particular, the hope for the longest possible preservation of the quality of life and capacity of patients, as well as slowing down the progression of the disease. 90% of respondents consider it necessary to continue (and even start) therapy even at a severe stage, despite the depletion of the effect. Memantine has become the main drug of choice in different regions of Russia as a drug with a wide range of registered indications, the fewest side effects and a low percentage of patient refusals.Keywords
This publication has 14 references indexed in Scilit:
- Assessment of the information provided by the medical specialist on Alzheimer's disease and that retained by the patient caregiversNeurología (English Edition), 2012
- Compliance assessment of ambulatory Alzheimer patients to aid therapeutic decisions by healthcare professionalsBMC Health Services Research, 2010
- Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer diseaseAlzheimer's Research & Therapy, 2009
- Memantine for dementiaEmergencias, 2006
- Functional Impairment, Healthcare Costs and the Prevalence of Institutionalisation in Patients with Alzheimer??s Disease and Other DementiasPharmacoEconomics, 2006
- Can elderly people take their medicine?Patient Education and Counseling, 2005
- Werden Demenzpatienten in Hausarztpraxen lege artis behandelt?Zeitschrift für Allgemeinmedizin, 2005
- Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer??s DiseasePharmacoEconomics, 2003
- A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)International Clinical Psychopharmacology, 2002
- Efficacy and Safety of Memantine in Patients With Mild to Moderate Vascular DementiaStroke, 2002